Background: Multiple myeloma (MM) is a neoplastic plasma cell disorder characterized by clonal proliferation of plasma cells in the bone marrow. Diverse hemostatic abnormalities have been reported in patients with myeloma which predispose to bleeding and also thrombosis. Methods: Complete blood count, biochemical parameters and parameters of hemostasis i.e. platelet count, prothrombin time (PT), activated partial thromboplastin time (APTT), thrombin time (TT), factor VIII assay results, plasma fibrinogen, D-dimer and lupus anticoagulant, were assessed in 29 MM patients and 30 age matched controls. Results: The most frequent abnormal screening parameter was APTT. Of the six indicative of a bleeding tendency i.e. thrombocytopenia, prolonged PT, APTT, TT, reduced plasma fibrinogen and factor VIII, at least one was abnormal in 8 (27.6%) patients. Of the four prothrombotic markers, lupus anticoagulant, D-dimer, elevated factor VIII and plasma fibrinogen, one or more marker was present in 24 (82.7%). D-dimer was the most common prothrombotic marker, being elevated in 22 (75.9%) patients. One or more laboratory parameter of hemostasis was abnormal in all 29 (100%) patients. Though thrombotic complications are reported to be less frequent as compared to hemorrhagic manifestations, one or more marker of thrombosis was present in 24 (82.7%) patients. Conclusion: This study provided laboratory evidence of hemostatic dysfunction which may be associated with thrombotic or bleeding complications at diagnosis in all MM patients. Hence, screening for these abnormalities at the time of diagnosis should help improved prognosis in such cases.
Gogia, A., Sikka, M., Sharma, S., & Rusia, U. (2018). Hemostatic Abnormalities in Multiple Myeloma Patients. Asian Pacific Journal of Cancer Prevention, 19(1), 127-130. doi: 10.22034/APJCP.2018.19.1.127
MLA
Aarti Gogia; Meera Sikka; Satender Sharma; Usha Rusia. "Hemostatic Abnormalities in Multiple Myeloma Patients". Asian Pacific Journal of Cancer Prevention, 19, 1, 2018, 127-130. doi: 10.22034/APJCP.2018.19.1.127
HARVARD
Gogia, A., Sikka, M., Sharma, S., Rusia, U. (2018). 'Hemostatic Abnormalities in Multiple Myeloma Patients', Asian Pacific Journal of Cancer Prevention, 19(1), pp. 127-130. doi: 10.22034/APJCP.2018.19.1.127
VANCOUVER
Gogia, A., Sikka, M., Sharma, S., Rusia, U. Hemostatic Abnormalities in Multiple Myeloma Patients. Asian Pacific Journal of Cancer Prevention, 2018; 19(1): 127-130. doi: 10.22034/APJCP.2018.19.1.127
)